Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details) - Schedule of warrant activity

v3.20.2
Stockholders' Deficit (Details) - Schedule of warrant activity - Warrant [Member]
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]  
Warrant Number of Shares outstanding at beginning | shares 502,250
Warrant Weighted Average Exercise Price outstanding at beginning | $ / shares $ 0.57
Warrant Weighted Average Remaining Contractual Term outstanding at beginning 3 years 357 days
Warrant Aggregate Intrinsic Value outstanding at beginning | $
Granted Number of Shares | shares 2,911,764
Granted Weighted Average Exercise Price | $ / shares $ 1.03
Granted Weighted Average Remaining Contractual Term 4 years 10 days
Granted Aggregate Intrinsic Value | $
Forfeited Number of Shares | shares
Forfeited Weighted Average Exercise Price | $ / shares
Forfeited Aggregate Intrinsic Value | $
Exercised Number of Shares | shares
Exercised Weighted Average Exercise Price | $ / shares
Exercised Aggregate Intrinsic Value | $
Expired Number of Shares | shares
Expired Weighted Average Exercise Price | $ / shares
Expired Aggregate Intrinsic Value | $
Warrant Number of Shares outstanding at ending | shares 3,414,014
Warrant Weighted Average Exercise Price outstanding at ending | $ / shares $ 0.96
Warrant Weighted Average Remaining Contractual Term outstanding at ending 3 years 259 days
Warrant Aggregate Intrinsic Value outstanding at ending | $ $ 607,929
Warrant Number of Shares exercisable at ending | shares 1,914,014
Warrant Weighted Average Exercise Price exercisable at ending | $ / shares $ 1.09
Warrant Weighted Average Remaining Contractual Term exercisable at ending 3 years 14 days
Warrant Aggregate Intrinsic Value exercisable at ending | $ $ 255,429